BiotechTube
Home/Frantz Viral Therapeutics/C. Richard Schlegel, MD, PhD
CR

C. Richard Schlegel, MD, PhD

Scientific Advisor / Inventor

Frantz Viral Therapeutics

Therapeutic Areas

Infectious DiseaseOncology

Frantz Viral Therapeutics Pipeline

DrugIndicationPhase
Artesunate Vaginal InsertCervical High-Grade Squamous Intraepithelial Lesion (HSIL)Phase 2B
Artesunate OintmentVulvar High-Grade Squamous Intraepithelial Lesion (HSIL)Phase 2B
Artesunate Anal SuppositoryAnal High-Grade Squamous Intraepithelial Lesion (HSIL) in HIV-negative patientsPhase 2B

Leadership Team at Frantz Viral Therapeutics

MG
Mark G. Frantz
Chairman and CEO
MP
Mihaela Plesa, BA, CCRP
Director, Clinical Research Programs
CL
Cornelia L. Trimble, MD
Scientific Advisor / Global PI for Cervical & Vulvar Trials
View full Frantz Viral Therapeutics profile